Eton Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eton Pharmaceuticals

10/08/2023 22:03

* Eton Pharmaceuticals Inc  ETON.OQ  reported quarterly
adjusted
earnings of 15 cents​​ per share for the quarter ended in June.
The lone analyst forecast for the quarter was for a loss of 9
cents per share.
    * Revenue rose 63% to $12.00 million from a year ago;
analysts
expected $6.51 million. 
    * Eton Pharmaceuticals Inc's reported EPS for the quarter
was 18
cents​.
    * The mean earnings estimate of analysts had risen by
about 25% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eton Pharmaceuticals Inc shares had fallen by 24.4% this
quarter and lost 6.4% so far this year.
    * The company reported quarterly net income of $4.56
million.
    * Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.09          0.15           Beat
 Mar. 31 2023      -0.14          -0.10          Beat
 Dec. 31 2022      0.01           0.04           Beat
 Sep. 30 2022      -0.15          -0.12          Beat